Opinion

Video

Managing Adverse Events and Toxicities HER2+ Metastatic Breast Cancer

Tiffany A. Traina, MD, addresses adverse event monitoring and the range of adverse events patients may experience with front-line treatments for HER2-positive metastatic breast cancer, particularly highlighting alopecia and diarrhea as common side effects.

Related Videos
2 KOLs are featured in this program.
2 KOLs are featured in this program.
Shipra Gandhi, MD
2 KOLs are featured in this series
2 KOLs are featured in this series
A panel of 5 experts on breast cancer
A panel of 5 experts on breast cancer
2 KOLs are featured in this series
Sheldon M. Feldman, MD
Rita Mukhtar, MD